Acta Neurologica Scandinavica · 2009 · 40 citations · 20 references
MedicineInfectious DiseasesNeurologyImmunology Of Infectious DiseasesNeuroimmunologyNeuroinfectious DiseasesCentral Nervous System InfectionsEncephalitisImmunodeficiency DisordersNeuropathology Of InfectionViral InfectionsAids-defining InfectionsCd4 T-cell DepletionHiv-associated ImmunosuppressionLong-term Clinical SuccessLong-term CoursePneumocystis InfectionToxoplasmosis Imaging
OBJECTIVES: We compared clinical long-term course and outcome in all AIDS patients admitted to our outpatient department from January, 1989 to June, 1998 with toxoplasma encephalitis (TE) as first AIDS-defining infection (n= 106) and in 106 patients with Pneumocystis carinii pneumonia (PCP) as first AIDS-defining disease. MATERIAL AND METHODS: The 2 groups were matched with respect to age, sex, risk group, degree of immunodeficiency as measured by CD4 cell counts and duration of HIV-1-positivity. TE was diagnosed radiologically and by response to treatment. RESULTS: Forty-three TE patients surviving the first TE symptoms > 14 months developed dementive symptoms, leucoencephalopathy in imaging procedures and died from dementia. In contrast only 5 patients surviving PCP for an equally long period showed dementive symptoms. CONCLUSION: Cerebral infections like toxoplasma encephalitis (TE) may negatively influence HIV-1-activity so far latent in the brain.
20